Cargando…

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Camptothecin (CPT) is a potent chemotherapeutic agent for various cancers, but the broader application of CPT is still hindered by its poor bioavailability and systemic toxicity. Here, a prodrug that releases CPT in response to glutathione (GSH), which is commonly overexpressed by cancer cells is re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lingpu, Zhu, Lin, Tang, Lin, Xie, Jiayi, Gao, Yajuan, Yu, Changyuan, Shang, Kun, Han, Hongbin, Liu, Chaoyong, Lu, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875659/ https://www.ncbi.nlm.nih.gov/pubmed/36442854 http://dx.doi.org/10.1002/advs.202205246

Ejemplares similares

Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug
por: Li, Wenhua, et al.
Publicado: (2021)

Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models
por: Shang, Kun, et al.
Publicado: (2023)

Self-Assembled Disulfide Bond Bearing Paclitaxel—Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy
por: Gao, Jingyan, et al.
Publicado: (2020)

Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
por: Ao, Mingtao, et al.
Publicado: (2021)

Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme
por: Checa-Chavarria, Elisa, et al.
Publicado: (2021)

Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy
por: Guo, Zhaopei, et al.
Publicado: (2022)

Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells
por: Su, Hao, et al.
Publicado: (2016)

Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs
por: Liang, Dinghua, et al.
Publicado: (2018)

Glutathione Transferase (GST)-Activated Prodrugs
por: Ruzza, Paolo, et al.
Publicado: (2013)

An Orally Bioavailable (Mice) Prodrug of Glutathione
por: Crankshaw, Daune L., et al.
Publicado: (2021)

Prodrug Approach for Increasing Cellular Glutathione Levels
por: Cacciatore, Ivana, et al.
Publicado: (2010)

Sustained delivery of a camptothecin prodrug – CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity
por: Dong, Dong, et al.
Publicado: (2019)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)

PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates
por: Xu, Bing, et al.
Publicado: (2018)

H(2)O(2)-responsive polymer prodrug nanoparticles with glutathione scavenger for enhanced chemo-photodynamic synergistic cancer therapy
por: Wang, Guanchun, et al.
Publicado: (2023)

Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin
por: Huarte, Judit, et al.
Publicado: (2021)

Glutathione boosting the cytotoxicity of a magnetic platinum(iv) nano-prodrug in tumor cells
por: Zhu, Zhenzhu, et al.
Publicado: (2016)

A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual‐responsive and CD206 targeting to improve the anti‐tumour effect
por: Wang, Changhai, et al.
Publicado: (2023)

Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K
por: Sjödin, Birgitta, et al.
Publicado: (2021)

A novel glutathione-triggered theranostic prodrug for anticancer and imaging in living cells
por: Zhang, Hengrui, et al.
Publicado: (2018)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
por: Castillo, Paula M, et al.
Publicado: (2014)

Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
por: Yang, Lu, et al.
Publicado: (2021)

Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants
por: Pavillard, V, et al.
Publicado: (2001)

Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin
por: Zhang, Lan, et al.
Publicado: (2013)

Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017)

Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
por: Wang, Weiwei, et al.
Publicado: (2020)

Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors
por: Sun, Mengchi, et al.
Publicado: (2022)

CuS nanoparticles and camptothecin co-loaded thermosensitive injectable hydrogel with self-supplied H(2)O(2) for enhanced chemodynamic therapy
por: Tang, Wenxue, et al.
Publicado: (2022)

Camptothecin effectively treats obesity in mice through GDF15 induction
por: Lu, Jun Feng, et al.
Publicado: (2022)

Maleimidation of dextran and the application in designing a dextran–camptothecin conjugate
por: Zhu, Qiwen, et al.
Publicado: (2018)

Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
por: Fu, Chen, et al.
Publicado: (2022)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Formation of nanoparticles by cooperative inclusion between (S)-camptothecin-modified dextrans and β-cyclodextrin polymers
por: Nielsen, Thorbjørn Terndrup, et al.
Publicado: (2015)

Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells
por: Yuan, Yu-Guo, et al.
Publicado: (2018)

Nanoparticle-Encapsulated Camptothecin: Epigenetic Modulation in DNA Repair Mechanisms in Colon Cancer Cells
por: Farhana, Aisha, et al.
Publicado: (2021)

Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis
por: Lin, Chien-Ju, et al.
Publicado: (2016)

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
por: Ye, Jiayi, et al.
Publicado: (2022)

Current perspectives on camptothecins in cancer treatment.
por: Dancey, J., et al.
Publicado: (1996)

Production of camptothecin in cultures of Chonemorpha grandiflora
por: Kulkarni, A. V., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_17uuk0mqga11pjfsp9l13hb8r1